Mission Statement

The mission of the Angelman, Rett and Prader-Willi Syndrome Consortium (ARPWSC) is to conduct clinical research and clinical trials to learn more about these disorders with the goal of developing new and better treatments to improve the care of patients with Angelman, Rett, and Prader-Willi Syndromes. The Consortium is also dedicated to clinical and scientific research in Angelman, Rett, and Prader-Willi Syndromes.  The Consortium also has laboratory researchers working to develop new treatments and new understandings for these disorders. We also seek to provide up-to-date information for patients and to assist in connecting patients with support groups, expert doctors, and clinical research opportunities.